Clinical Trial Update: A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL [NA]

View source ↗

Summary

Clinical trial update for a study evaluating ultra-fraction radiotherapy as bridging therapy before CAR-T in relapsed/refractory diffuse large B-cell lymphoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CAR-T therapy (Chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Diffuse Large B Cell Lymphoma, CAR-T | NA | Status: RECRUITING